ThymuPlex Immune Formula
On sale on the US market (according to the DSLD)
Nature's Way, food supplement from the US market
ThymuPlex Immune Formula (Nature's Way), a food supplement au code-barres 763948039951, is described by its US market label. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. Doses of vitamine A are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 250 mg a day according to the label (at most 1 serving a day), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Vitamine E: up to 134 mg a day according to the label (at most 1 serving a day), above the maximum dose of 30 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Nature's Way
- Barcode
- 763948039951
- Form
- Capsule
- One serving
- 4 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Gelatin, Cellulose, Magnesium Stearate, Silica, Lactose Monohydrate, Titanium Dioxide color
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Calories | Other | 5 Calorie(s) |
| Cholesterol | Fat | not stated |
| Protein | Protein | not stated |
| Vitamin A | Vitamin | 7,500 µg |
| Vitamin C | Vitamin | 250 mg |
| Vitamin E | Vitamin | 134 mg |
| Zinc | Mineral | 15 mg |
| Selenium | Mineral | 25 µg |
| Proprietary Thymus & Glandular Complex | Blend | 900 mg |
| Thymus | Ingredient of animal origin | not stated |
| Spleen | Ingredient of animal origin | not stated |
| Lymphatic | Ingredient of animal origin | not stated |
| Trypsin | Enzyme | not stated |
| Papain | Enzyme | not stated |
| Bromelain | Enzyme | not stated |
| Echinacea purpurea (Echinacea purpurea) | Plant | 300 mg |
| Lysine | Amino acid | 250 mg |
| Fennel | Plant | 65 mg |
| Goldenseal root extract (Hydrastis canadensis) | Plant | 64 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: ThymuPlex Immune Formula
Entered into DSLD on 22 December 2019. Withdrawn from the US market on 1 October 2019 (according to the DSLD).Same active composition.
Official label: ThymuPlex Immune Formula
Entered into DSLD on 21 September 2017. Withdrawn from the US market on 12 March 2019 (according to the DSLD).- Active ingredient added : Thumus Polypeptide Fractions (quantity not stated)
- Active ingredient added : Total Carbohydrates (< 1 Gram(s))
- Active ingredient removed : Calories (5 Calorie(s))
- Active ingredient removed : Cholesterol (< 5 mg)
- Same quantity, different name: Proprietary Thymus Polypeptide Fractions & Glandular Complex in this version; Proprietary Thymus & Glandular Complex on the displayed label (900 mg)
- Different unit, without conversion : Vitamin A: 25,000 IU in this version; 7,500 mcg on the displayed label
- Different unit, without conversion : Vitamin E: 200 IU in this version; 134 mg on the displayed label
Official label: ThymuPlex Immune Formula
Entered into DSLD on 24 November 2015. Withdrawn from the US market on 12 April 2017 (according to the DSLD).- Active ingredient added : Thymus Polypeptide fractions (quantity not stated)
- Active ingredient added : Total Carbohydrates (1 Gram(s))
- Active ingredient removed : Calories (5 Calorie(s))
- Active ingredient removed : Cholesterol (< 5 mg)
- Active ingredient removed : Protein (< 1 Gram(s))
- Same quantity, different name: L-Lysine in this version; Lysine on the displayed label (250 mg)
- Same quantity, different name: Proprietary Thymus Polypeptide Fractions/Glandular Complex in this version; Proprietary Thymus & Glandular Complex on the displayed label (900 mg)
- Different unit, without conversion : Vitamin A: 25,000 IU in this version; 7,500 mcg on the displayed label
- Different unit, without conversion : Vitamin E: 200 IU in this version; 134 mg on the displayed label
Official label: ThymuPlex Immune Booster
Entered into DSLD on 25 November 2014. Withdrawn from the US market on 9 November 2015 (according to the DSLD).- Active ingredient added : Thymus Polypeptide fractions (quantity not stated)
- Active ingredient added : Total Carbohydrates (1 Gram(s))
- Active ingredient removed : Calories (5 Calorie(s))
- Active ingredient removed : Cholesterol (< 5 mg)
- Active ingredient removed : Protein (< 1 Gram(s))
- Same quantity, different name: Goldenseal (Hydrastis canadensis) root extract in this version; Goldenseal root extract on the displayed label (64 mg)
- Same quantity, different name: Proprietary Thymus Polypeptide Fractions/Glandular Complex in this version; Proprietary Thymus & Glandular Complex on the displayed label (900 mg)
- Different unit, without conversion : Vitamin A: 25,000 IU in this version; 7,500 mcg on the displayed label
- Different unit, without conversion : Vitamin E: 200 IU in this version; 134 mg on the displayed label
Official label: ThymuPlex Immune Booster
Entered into DSLD on 25 September 2013. Withdrawn from the US market on 24 October 2014 (according to the DSLD).- Active ingredient added : Lymphatic extract (quantity not stated)
- Active ingredient added : Spleen extract (quantity not stated)
- Active ingredient added : Thymus extract (quantity not stated)
- Active ingredient added : Thymus Polypeptide fractions (quantity not stated)
- Active ingredient added : Total Carbohydrates (< 1 Gram(s))
- Active ingredient removed : Cholesterol (< 5 mg)
- Active ingredient removed : Lymphatic (quantity not stated)
- Active ingredient removed : Spleen (quantity not stated)
- Active ingredient removed : Thymus (quantity not stated)
- Same quantity, different name: Goldenseal in this version; Goldenseal root extract on the displayed label (64 mg)
- Same quantity, different name: L-Lysine in this version; Lysine on the displayed label (250 mg)
- Same quantity, different name: Proprietary Thymus Polypeptide Fractions/Glandular Complex in this version; Proprietary Thymus & Glandular Complex on the displayed label (900 mg)
- Different unit, without conversion : Calories: 5 {Calories} in this version; 5 Calorie(s) on the displayed label
- Different unit, without conversion : Vitamin A: 25,000 IU in this version; 7,500 mcg on the displayed label
- Different unit, without conversion : Vitamin E: 200 IU in this version; 134 mg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Echinacea purpurea
Read the warning, when it applies and the studies cited
ECHINACEA - ECHINACEA PURPUREA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, or an immune system disorder (EMA 2015; Gardner and McGuffin 2013; Brinker 2010).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2015: European Medicines Agency (GB). EMA/HMPC/48704/2014. European Union herbal monograph on Echinacea purpurea (L.) Moench, herba recens. Final. [Accessed 2024 December 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-echinacea-purpurea-l-moench-herba-recens_en.pdf
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications to suppress the immune system (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
Condition of application: Preparations containing herb top.
Stop use if hypersensitivity/allergy occurs (MHRA 2018; EMA 2015; Kligler 2003; WHO 1999).
Sources cited by Health Canada (5)
- EMA 2015: European Medicines Agency (GB). EMA/HMPC/48704/2014. European Union herbal monograph on Echinacea purpurea (L.) Moench, herba recens. Final. [Accessed 2024 December 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-echinacea-purpurea-l-moench-herba-recens_en.pdf
- Kligler B. 2003. Echinacea. American Family Physician 67(1):77-80. [Accessed 2024 February 22]. Available from: http://www.aafp.org/afp/2003/0101/p77.html
- MHRA 2018: Medicines and Healthcare products Regulatory Agency (GB). Press release: Echinacea herbal products should not be used in children under 12 years old. [Accessed 2024 December 11]. Available from: https://webarchive.nationalarchives.gov.uk/ukgwa/20140208035927/http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON180627
- WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.
- OMS 1999: Organisation mondiale de la santé (OMS). Monographs on Selected Medicinal Plants : Volume 1. Geneva (CHE) : Organisation mondiale de la santé; 1999.
- Lysine
Read the warning, when it applies and the studies cited
LYSINE
Route of administration: Oral
Cautions and warnings
Applies to products providing more than 300 mg of lysine, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Goldman and Ausiello 2004).
Sources cited by Health Canada (1)
- Goldman L, Ausiello D, editors. Cecil Textbook of Medicine, Volume 1, 22nd edition. Philadelphia (PA): Saunders; 2004.
- Goldenseal root extract
Read the warning, when it applies and the studies cited
GOLDENSEAL - HYDRASTIS CANADENSIS - Buccal
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Ask a health care practitioner/health care provider/health care professional/ doctor/physician before use if you have a kidney or blood pressure disorder (Brinker 2010; Hoffmann 2003).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
Contraindications
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes and al. 2007; Mills and Bone 2005; Boon and Smith 2004; Hoffmann 2003; Bradley 1992).
Sources cited by Health Canada (7)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (GB): The Pharmaceutical Press; 2007.
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Bradley PR, editor. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association; 1992.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Health Canada monograph dated 28 March 2025
GOLDENSEAL - HYDRASTIS CANADENSIS - Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional before use if you have a kidney or blood pressure disorder (Brinker 2010; Hoffmann 2003).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Hoffmann D. 2003. Medical Herbalism. Rochester (VT): Healing Arts Press.
Contraindications
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes and al. 2007; Mills and Bone 2005; Boon and Smith 2004; Hoffmann 2003; Bradley 1992).
Sources cited by Health Canada (7)
- Barnes J, Anderson LA, Philipson JD. 2007. Herbal Medicines, 3rd edition. London (GB): The Pharmaceutical Press.
- Boon H, Smith MJ. 2004. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc.
- Bradley PR, editor. 1992. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- Hoffmann D. 2003. Medical Herbalism. Rochester (VT): Healing Arts Press.
- Mills S, Bone K. 2005. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Nature's Way
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “ThymuPlex Immune Formula (Nature's Way): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/763948039951-thymuplex-immune-formula-nature-s-way, updated 22 December 2019.